BioSpace News Archive

Policy

Pfizer Inc. Sets Aside $491 Million for Rapamune Marketing

November 2, 2012
·
1 min read
Biotech Bay

Oculus Innovative Sciences, Inc. to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy

November 2, 2012
·
1 min read
Business

Novavax, Inc. Reports Third-Quarter 2012 Financial Results

November 2, 2012
·
1 min read
Bio NC

Southeast BIO (SEBIO) Recognizes Argos Therapeutics, Inc. With the “2012 Southeast BIO Deal of the Year: Venture Capital Transaction” Award

November 2, 2012
·
1 min read
TopoTarget A/S Release: Notice to Convene Extraordinary General Meeting

November 2, 2012
·
1 min read
Biotech Beach

Meade Instruments Release: LX80 Mount -- Interstellarum Magazine Product of the Year for 2012

November 2, 2012
·
1 min read
Drug Development

Aegerion Pharmaceuticals, Inc. Announces Publication in the Lancet of Data From Its Pivotal Phase III Study of Lomitapide in Adult Patients With Homozygous Familial Hypercholesterolemia (HoFH)

November 2, 2012
·
1 min read
Business

Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Announces the Signing of Their First Agreement to Market an Authorized Generic Drug (Parnate® Product) With Covis Pharma S.a.r.l.

November 2, 2012
·
1 min read
Business

Vical Incorporated Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines

November 2, 2012
·
1 min read
BioTie Therapies Corp. Interim Report 1 January - 30 September 2012

November 2, 2012
·
1 min read